SRDX Stock Price, Chart, Stats & News

Surmodics, Inc.
Save
614.51M
Market cap
–
Current P/E
208.33x
Forward P/E
SRDX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 73.09% |
Operating margin | -10.22% |
Pretax margin | -12.16% |
Net margin | -14.59% |
Effective tax rate | -19.98% |
ROA | -10.38% |
ROE | -15.59% |
D/E | 0.29x |
Interest coverage ratio | -3.54x |
SRDX valuation
P/E | – |
P/S | 5.09x |
P/B | 5.51x |
P/CF | -326.14x |
P/FCF | -173.30x |
P/OCF | -326.14x |
PEG | -3.03x |
EV multiple | -73.91x |
About
Surmodics, Inc., together with its affiliates, specializes in providing advanced surface modification solutions tailored for intravascular medical devices. Additionally, the company supplies specialized chemical components essential for in vitro diagnostic immunoassay tests and microarrays. Its operations span both the United States and international markets.
Similar securities
Based on sector and market capitalization
Report issue











